Skip to content

Public FDA record

K150717: Megasorb, Mitsu, Mitsu FST, Filaxyn, Filapron

510(k) clearance K150717 for M/s. Meril Endo Surgery Private Limited.. View source facts, labeled dates, and the original FDA record.

FDA identifier
K150717
Company in FDA record
M/s. Meril Endo Surgery Private Limited.
FDA decision date
Oct 14, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026

Decision stated in the source

Substantially Equivalent

Source facts

Decision
Substantially Equivalent
Received
2015-03-19
Specialty
General, Plastic Surgery
Decision code
SESE
Clearance type
Traditional

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗